Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of LacTEST for the Diagnosis of Hypolactasia in Adults and Elderly Patients Presenting With Clinical Symptoms of Lactose Intolerance

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Adults of either sex, between 18 and 70 years old.~2. Capacity for understanding and giving the informed consent to participate in this study.~3. Patients with clinical suggestive of lactose intolerance, primary or secondary, who have not been diagnosed and that fulfil the requirements allowed by the gaxilose summary of product characteristics (SmPC).~Exclusion Criteria:~1. Pregnant women or breast-feeding women.~2. Unable or reticent to give the informed consent or to comply with the study requirements.~3. Patients with glomerular filtration rate (GFR) less than 90 ml/min/1.73m2.~4. Portal hypertension: ascites, cirrhosis.~5. Medical records of total gastrectomy and/or vagotomy.~6. Patients diagnosed with myxedema.~7. Patients with Diabetes Mellitus.~8. Patients who are participating or have participated in any clinical trial within the 3 months previous to their inclusion in the study.~9. Patients who are drug abuse consumers.~10. Patients under treatment with antibiotics, sulphamides and antiparasitics, who cannot suspend the treatments 7 days prior to the performance of the hydrogen breath test.~11. Patients with any recognized and already existing disorder that might interfere with the any of the lactose intolerance diagnosis tests.~12. Patients who have taken aspirin of indomethacin in the 48h preceding the performance of the Gaxilose test.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- LacTEST (Type: EXPERIMENTAL): 0,45 g of gaxilose po, once, per diagnostic test performed.
- Hydrogen Breath Test (Type: ACTIVE_COMPARATOR): 25 to 50 g of lactose po, once, per diagnostic test performed.

Based on this trial design, predict the completion outcome and termination type (if applicable).